← Alle mensen

CC

Chao-Hua Chiu

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Eerstelijns Lorlatinib Versus Crizotinib in Asian Patiënten met Gevorderd ALK-Positive NSCLC: Five-Year Outcomes From...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-07

RELAY: Final Totale overleving for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-04

Nivolumab plus chemotherapie bij EGFR-gemuteerd NSCLC na TKI: CheckMate 722 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024

Tiragolumab plus atezolizumab plus chemo bij uitgebreid SCLC: SKYSCRAPER-02 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2024

Ramucirumab plus erlotinib bij onbehandeld EGFR-gemuteerd NSCLC: RELAY fase III

The Lancet. Oncology · 2019-12